Forus vs Plenful (2026)
Both work pharmacy adjacent operations and they are pointed at different money. Forus automates the path from prescription to patient, generating and submitting prior authorisations, drafting appeals, routing to pharmacy and finding affordability help, and it is free to the prescriber. Plenful automates pharmacy operations with a centre of gravity in drug pricing programme compliance, where eligibility screening and documentation decide whether a health system keeps savings it has already banked. They are complementary rather than competing: one gets the medicine to the patient, the other protects the margin on it. The question for Forus is who pays, since a free platform that routes prescriptions has an economic interest somewhere. The question for Plenful is whether its screening is tuned to qualify correctly or to qualify more, which look the same until an audit.
- It automates the path from prescription to patient, generating and submitting prior authorisations, drafting appeals, routing to pharmacy and finding affordability programmes, and it is free to the provider.
- The system acts rather than recommends, completing and submitting forms, with a stated business associate commitment and a typed attestation.
- For a prescriber whose problem is that medications never reach patients, this is aimed at the abandonment point directly.
- It is scoped to pharmacy and healthcare operations with a centre of gravity in the drug pricing programme compliance that decides whether a health system keeps its savings.
- Named customers including large health systems, with language models investigating unstructured record data for eligibility rather than only screening claims.
- Compliance in that programme is audited and consequential, so a tool built for it addresses a risk the organisation already has to manage.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Forus and Plenful are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Forus | Plenful |
|---|---|---|
| Primary category | RCM & Prior Auth AI | Healthcare Administrative Automation |
| Founded | 2022 | Not recorded |
| Headquarters | New York, New York, United States | San Francisco, California |
| Website | forus.com | plenful.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Forus its top capability grade on AI Centrality and HIPAA and BAA Posture. Set against Plenful, Forus grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Plenful its top capability grade on Setting and Specialty Coverage. Set against Forus, Plenful grades higher on Clinical and Operational Evidence, FDA and Regulatory Status and Setting and Specialty Coverage. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Forus or Plenful?
On the axes where the AI Health Index separates them, Forus grades higher on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship, and Plenful grades higher on Clinical and Operational Evidence, FDA and Regulatory Status and Setting and Specialty Coverage. Forus leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Forus and Plenful differ most?
The widest separation the AI Health Index records between Forus and Plenful is on HIPAA and BAA Posture, where Forus grades A and Plenful grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Forus and Plenful grade the same?
The AI Health Index grades Forus and Plenful the same on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and AI Governance and Bias Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Forus and Plenful not disclosed?
At the last review, at least one of Forus and Plenful published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
A product free to the provider is paid for by someone else, and in medication access that is usually a manufacturer or a pharmacy channel, so establish who funds it and what data flows back, because a platform routing prescriptions has an interest in where they land. Plenful publishes no attestation, health privacy statement, business associate terms, retention position or training use statement. Neither publishes an accuracy figure or a governance framework. In drug pricing programme work the specific exposure is that a tool tuned to maximise qualifying claims and one tuned to qualify correctly look identical until an audit.